Taiwan restricts prescription of drugs containing montelukast

Taiwan's Food and Drug Administration (FDA) has decided to impose restrictions on the prescription of drugs containing montelukast for patients suffering allergic nose inflammation, ruling that such medications should only be prescribed after other drugs have been used and failed to be effective.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)